TraceLink Partners with Saudi Azm to Help Pharma Manufacturers Achieve Compliance
TraceLink has partnered with Saudi Azm, a leading system integrator and IT solutions provider to pharmaceutical businesses in the Kingdom of Saudi Arabia to help companies successfully comply with the aggregation and reporting regulations required by the Saudi Food and Drug Authority.
TraceLink Announces Q3 2019 Company and Financial Results
TraceLink announces continued success in global customer and network growth during the third quarter of 2019 success, with 1,250 customers across 50 countries and over 10,700 connections on the TraceLink Digital Network. Other recent Company highlights include the announcement of TraceLink’s Digital Network Platform, further transforming the global pharmaceutical supply chain.
DSCSA Saleable Returns Enforcement Discretion; A Letter from TraceLink’s CEO
The FDA has announced a 12-month delay in enforcement action for the DSCSA saleable returns verification requirement applicable to wholesale distributors but not to manufacturers. What does this mean for the industry? In an open letter, TraceLink’s President and CEO, Shabbir Dahod, shares his insights.
Why an Open, Standards-Based Approach is Essential for the Pharma Supply Chain
A proven partner or just a vendor? Your investment in serialization should set you on a path to create transformational value for your business. With a trusted partner, this is possible. Understand the importance of an open, standards-based approach and the five critical questions you should ask to ensure you choose a proven partner with expertise to guide you, and not just a vendor.